Description

4-((3-(Ethoxycarbonyl)-4,5,6,7-Tetrahydrobenzo[B]Thiophen-2-Yl)Amino)-4-Oxobutanoic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities and proprietary drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug molecules, especially those targeting central nervous system (CNS) disorders or acting as enzyme inhibitors.
• Organic Synthesis Building Block: Utilized in research and development for constructing novel heterocyclic compounds and exploring new chemical spaces in medicinal chemistry.
• Agrochemical Research: Serves as a starting material or intermediate in the development of new crop protection agents and herbicides due to its fused ring system.
• Material Science Applications: Potential use in the synthesis of specialty polymers or organic electronic materials where specific molecular recognition or charge transport properties are desired.

Basic Information

Product Name	4-((3-(Ethoxycarbonyl)-4,5,6,7-Tetrahydrobenzo[B]Thiophen-2-Yl)Amino)-4-Oxobutanoic Acid
CAS No.	62159-41-5
Molecular Formula	C15H19NO5S
Molecular Weight	325.38 g/mol
Synonyms	4-[(3-Ethoxycarbonyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)amino]-4-oxobutanoic acid; 4-Oxo-4-[(3-ethoxycarbonyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino]butanoic acid; 2-[(3-Carbethoxy-4,5,6,7-tetrahydrobenzo[b]thien-2-yl)amino]-2-oxoacetic acid derivative; Succinamic acid, N-(3-ethoxycarbonyl-4,5,6,7-tetrahydrobenzo[b]thien-2-yl)-; Butanedioic acid, 2-[(3-ethoxycarbonyl-4,5,6,7-tetrahydrobenzo[b]thien-2-yl)amino]-2-oxo-
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency and high purity. Quality is verified through a comprehensive suite of analytical techniques including HPLC, NMR, and mass spectrometry. A Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment. We support compliance with cGMP and ICH Q7 guidelines for pharmaceutical intermediates upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.